infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 353 articles from: Treatment issues

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Updated CDC Guidance for Healthcare Personnel With Potential Exposure to HCV

    Infectious Disease Advisor / 24 August 2020

  • Scotland: NHS Tayside claims it has 'effectively eliminated' hepatitis C

    BBC Scotland / 28 July 2020

  • World Hepatitis Day: COVID-19's impact on hepatitis elimination

    Australian Hospital & Healthcare Bulletin / 27 July 2020

  • Increasing access to hepatitis C treatment in Ukraine

    MSF / 09 June 2020

  • FDA OKs Gilead’s paediatric hep C drug

    Pharma Times / 25 March 2020

  • Access To Hepatitis C Treatment And Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected

    Hep C Coalition / 13 February 2020

  • AbbVie Receives Positive CHMP Opinion for MAVIRET® to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis

    AbbVie press release / 04 February 2020

  • Program Provides Medical Lockers For Homeless People To Store Prescriptions

    CBS Miami / 21 January 2020

  • How to Check Drug Interactions With Hep C Medications

    Filter / 07 January 2020

  • HCV Guidance Updates Recommendations for Identification and Management of Chronic Hep C

    AASLD press release / 04 December 2019

← Prev12345...36Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//